Ucb Biopharma Srl
Clinical trials sponsored by Ucb Biopharma Srl, explained in plain language.
-
Extended trial tests Long-Term safety of eye muscle weakness treatment
Disease control Not yet recruitingThis study continues testing rozanolixizumab to see if it's safe and effective for adults with ocular myasthenia gravis over a longer period. The treatment aims to control eye muscle weakness symptoms like drooping eyelids and double vision. Participants must have completed a pre…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Apr 01, 2026 22:11 UTC
-
New drug trial targets debilitating eye muscle weakness
Disease control Not yet recruitingThis study aims to test whether an investigational drug called rozanolixizumab can safely reduce eye muscle weakness and improve quality of life for adults with ocular myasthenia gravis. About 120 participants will receive either the drug or a placebo for 43 days while researcher…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC